CN Patent

CN105085593A — 瑞加德松的晶型及其制备方法

Assigned to SHANGHAI ZIYUAN PHARMACEUTICAL CO Ltd · Expires 2015-11-25 · 10y expired

What this patent protects

本发明涉及药物化学领域，公开了瑞加德松的新的结晶形式即瑞加德松晶型E，以及瑞加德松的新的结晶形式的制备方法。本发明所述瑞加德松晶型E在放射性核素心机灌注成像方面性能优异，并且其毒性弱，具有良好的储存稳定性，可用于制备用于放射性核素心机灌注成像应激剂的药物。

USPTO Abstract

本发明涉及药物化学领域，公开了瑞加德松的新的结晶形式即瑞加德松晶型E，以及瑞加德松的新的结晶形式的制备方法。本发明所述瑞加德松晶型E在放射性核素心机灌注成像方面性能优异，并且其毒性弱，具有良好的储存稳定性，可用于制备用于放射性核素心机灌注成像应激剂的药物。

Drugs covered by this patent

Patent Metadata

Patent number
CN105085593A
Jurisdiction
CN
Classification
—
Expires
2015-11-25
Drug substance claim
No
Drug product claim
No
Assignee
SHANGHAI ZIYUAN PHARMACEUTICAL CO Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.